1. Home
  2. VEEE vs OGEN Comparison

VEEE vs OGEN Comparison

Compare VEEE & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Vee PowerCats Co.

VEEE

Twin Vee PowerCats Co.

HOLD

Current Price

$5.95

Market Cap

2.9M

Sector

Industrials

ML Signal

HOLD

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.62

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VEEE
OGEN
Founded
1994
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
2.7M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
VEEE
OGEN
Price
$5.95
$0.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
133.7K
56.3K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,819,130.00
N/A
Revenue This Year
$3.24
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.99
N/A
52 Week Low
$0.14
$0.50
52 Week High
$8.80
$5.24

Technical Indicators

Market Signals
Indicator
VEEE
OGEN
Relative Strength Index (RSI) 55.98 51.12
Support Level $5.42 $0.56
Resistance Level $7.44 $0.65
Average True Range (ATR) 0.62 0.04
MACD -0.27 0.01
Stochastic Oscillator 32.84 58.78

Price Performance

Historical Comparison
VEEE
OGEN

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.

About OGEN Oragenics Inc.

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

Share on Social Networks: